Featured Article
Dr. Reddy's Announces Three Generic Product Launches In The US Market
Dr. Reddy's Laboratories recently announced that it has launched the following three products in the US market:
Donepezil Hydrochloride tablets (5mg and 10mg strengths), a bioequivalent generic version of ARICEPT tablets. The Food & Drug Administration (FDA) approved Dr. Reddy's ANDA for Donepezil HCl tablets on May 31, 2011. Both strengths of Dr. Reddy's Donepezil Hydrochloride tablets are available in 30, 90 and 500 count bottles.
Venlafaxine Hydrochloride Extended Release capsules (37.5mg, 75mg and 150mg strengths), a bioequivalent generic version of EFFEXOR XR Extended Release capsules. The Food & Drug Administration (FDA) approved Dr. Reddy's ANDA for Venlafaxine Hydrochloride Extended Release Capsules on May 05, 2011. All three strengths of Dr. Reddy's Venlafaxine Hydrochloride Extended Release Capsules are available in 30, 90 and 500 count bottles.
Letrozole tablets, USP (2.5mg), a bioequivalent generic version of FEMARA. The Food & Drug Administration (FDA) approved Dr. Reddy's ANDA for Letrozole tablets, USP on June 3, 2011. Dr. Reddy's Letrozole tablets, USP are available in 30 count bottles. 
Millions of children in the world's poorest countries could receive vaccination against rotavirus diarrhoeal disease
GSK announced that it has made a new offer to supplyits rotavirus vaccine, RotarixTM, to the GAVI Alliance at $2.50 per dose, a small fraction of developed world prices. This announcement is part of the company's efforts to increase access to its medicines and vaccines in the world's poorest countries. It is estimated that more than half a million children die of rotavirus gastroenteritis each year - the equivalent of a child a minute worldwide(1) - and it is responsible for the hospitalization of millions more
Johnson & Johnson’s Zytiga set to earn peak sales of $910 million for metastatic castrate-resistant prostate cancer; study
US health care giant Johnson & Johnson’s (NYSE: JNJ) Zytiga (abiraterone acetate) will earn peak year sales of $910 million in the USA, France, Germany, Italy, Spain, UK and Japan for the treatment of metastatic castrate-resistant prostate cancer (MCRPC), according to a new report from advisory firm Decision Resources.
Increasing market access in Europe for biopharma companies
The biopharmaceutical industry is at a tipping point. Whilst the majority of companies have already been through the considerable pain associated with drastically cutting the field sales force and creating Key Account Management teams, today’s increasingly complex, fragmented and payer-led health economy is presenting new and very real challenges, according to an exclusive survey on biopharmaceutical from relations management specialist Cegedim. 
Novo pays $26.7 million to settle US marketing probes
Another day and another drugmaker, this time Novo Nordisk, is coughing up to settle investigations into marketing practices in the USA.
Glenmark gets final USFDA nod for skin ointment
Drug firm Glenmark today said it has received final approval from the US health regulator for its generic Mupirocin ointment, used for the treatment of bacterial skin infections.
India, Germany sign MoU on biomedical research
The Indian Council of Medical Research (ICMR) and Helmholtz Association (HGF), Germany have signed a signed new Memorandum of Understanding (MoU) on translational efforts in biomedical research for a period of next five years.
Elder Pharma to sell Indian brands in European market
Drug maker Elder Pharmaceuticals Ltd will soon roll out its leading Indian brands in the European market through its subsidiaries in Britain and Bulgaria, to step up its exports in the region
Drug companies reduce vaccine rates in developing nations
Numerous drug firms have bought down the prices of the vaccine in the developing world. Pharmaceutical companies such as GlaxoSmithKline (GSK), Merck, Johnson & Johnson and Sanofi-Aventis have decided to bring down the rates via the international vaccine alliance Gavi.
India to be world's 3rd largest light vehicles market by 2020
India will become the third largest market in the world after China and the US for light vehicles, including passenger cars and light commercial vehicles (LCVs), by 2020, according to market research firm JD Power Asia Pacific
India develops technology to fight aliens in the sea
India has developed an eco-friendly technology to treat sea water brought in by cargo ships into our domain, bringing along with it alien organisms and may be even radioactive elements that harm the marine ecosystem or can have even bigger consequences.
US diver launches underwater search for Osama's body Eccentric California salvage diver and entrepreneur Bill Warren, 59, has announced that he wants to find Osama Bin Laden's body as proof the Al Qaeda leader is really dead.
Swami Ramdev ends anti-graft fast Popular yoga guru Swami Ramdev on Sunday called off his eight-day-old hunger strike to denounce corruption after prominent spiritual figure Sri Sri Ravi Shankar persuaded him to end his action
|
Global @ Podium
Indian @ Podium
Also @ Podium
21st -23th June, 2011
Venue:- Shanghai, China
Details:- Click Here
23th June, 2011
Venue:- Hyatt Regency Cambridge
Details:- Click Here
1st to 4th July, 2011
Venue:- HITEX Exhibition Center, Hyderabad, India
Visit us at Stall:- 1.59
Details:- Click Here
17th -29th Sept. , 2011
Venue:- Gujarat University Hall, Ahmedabad
Details:- Click Here
30th Nov -2nd Dec, 2011
Venue:- Bombay Exhibition Center
Details:- Click Here
|
